Rochester Center for Behavioral Medicine

Rochester Center for Behavioral Medicine in Rochester Hills, Michigan offers a dedicated Spravato (esketamine) Treatment Resistant Depression Clinic for adults with treatment-resistant depression or major depressive disorder with acute suicidal ideation. Spravato is an FDA-approved nasal spray that works as an NMDA receptor antagonist, boosting glutamate to enhance communication between brain cells and potentially deliver faster relief than conventional antidepressants.

Treatment is provided safely in-office, with medical director Dr. Joel Young, a primary investigator during the Spravato clinical trial, and an experienced clinical team bringing over 30 years of behavioral health experience. Sessions last about two hours in a private treatment room with monitoring throughout, following an induction and maintenance schedule.

RCBM also offers care for addiction, ADHD, anxiety, autism, mood and sleep disorders, eating disorders, trauma, and weight management.